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IL-10 plays an important role in the control
of inflammation but not in the bacterial
burden in S. epidermidis CNS catheter
infection
Yenis M. Gutierrez-Murgas2, Gwenn Skar1, Danielle Ramirez3, Matthew Beaver1 and Jessica N. Snowden1,2*
Abstract
Background: Shunt infection is a frequent and serious complication in the surgical treatment in hydrocephalus.
Previous studies have shown an attenuated immune response to these biofilm-mediated infections. We proposed
that IL-10 reduces the inflammatory response to Staphylococcus epidermidis (S. epidermidis) CNS catheter infection.
Methods: In this study, a murine model of catheter-associated S. epidermidis biofilm infection in the CNS was
generated based on a well-established similar model for S. aureus. The catheters were pre-coated with a clinically
derived biofilm-forming strain of S. epidermidis (strain 1457) which were then stereotactically implanted into the
lateral left ventricle of 8-week-old C57BL/6 and IL-10 knockout (IL-10 knockout) mice. Bacterial titers as well as
cytokine and chemokine levels were measured at days 3, 5, 7, and 10 in mice implanted with sterile and S.
epidermidis-coated catheters.
Results: Cultures demonstrated a catheter-associated and parenchymal infection that persisted through 10 days
following infection. Cytokine analysis of the tissue surrounding the catheters revealed greater levels of IL-10, an
anti-inflammatory cytokine, in the infected group compared to the sterile. In IL-10 KO mice, we noted no change
in bacterial burdens, showing that IL-10 is not needed to control the infection in a CNS catheter infection model.
However, IL-10 KO mice had increased levels of pro-inflammatory mediators in the tissues immediately adjacent
to the infected catheter, as well as an increase in weight loss.
Conclusions: Together our results indicate that IL-10 plays a key role in regulating the inflammatory response to
CNS catheter infection but not in control of bacterial burdens. Therefore, IL-10 may be a useful therapeutic target
for immune modulation in CNS catheter infection but this should be used in conjunction with antibiotic therapy
for bacterial eradication.
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Background
Cerebrospinal fluid shunt placement for the treatment of
hydrocephalus is one of the most common procedures
performed by pediatric neurosurgeons in the USA, with
tens of thousands of shunts implanted annually [1].
Unfortunately, 30–40 % of all shunts placed in pediatric
patients fail within the first year, resulting in a shunt
revision to a primary placement ratio of 3:1 in many
health-care centers [1, 2]. One of the most common
causes of shunt failure is infection, reported in 5–30 %
of cases [2]. This equates to approximately 2400 hospital
admissions each year, with an increase in seizure
frequency and intelligence quotient (IQ) loss in many
children, who represent the highest risk population for
these infections [2–4]. The most common organism
responsible for shunt infections, Staphylococcus epider-
midis (S. epidermidis), is known to form biofilms, which
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are communities of bacterial cells that aggregate on the
catheter surface, encased in a protective self-produced
matrix [2, 5]. The biofilm’s recalcitrance to antimicrobial
agents makes it difficult to manage central nervous
system (CNS) catheter infections non-surgically, such
that catheter removal is currently required for effective
treatment [2, 6]. Studies designed to advance our under-
standing of the unique immune response to shunt
infections in children are needed to develop improved
diagnostic, treatment, and prevention strategies for these
serious infections.
Our laboratory developed a murine model of CNS
catheter infection to generate a consistent catheter-
associated infection with Staphylococcus aureus (S. aur-
eus), mimicking what is seen in humans with ventricular
shunt infections [7]. Using this model, we have been able
to demonstrate a relative decrease in inflammation in
biofilm infections in the brain, as compared to abscess
or infection with biofilm-deficient strains of bacteria [8].
This suggests that there is an alteration in the immune
response to biofilm infections, possibly contributing to
the persistence of these infections in patients. One
potential cause of the skewed immune response to these
biofilm infections is an increase in interleukin-10 (IL-10),
which may play a role in regulating inflammatory re-
sponses in this setting. IL-10 is a potent anti-inflammatory
cytokine that can be produced by both innate and adaptive
immune cells [9]. IL-10 polymorphisms in humans and
mice have been associated with an increase in auto-
immune disease, such as inflammatory bowel disease,
atopic dermatitis, and wheezing, as well as an increased
inflammatory response to some microbial pathogens
[9–12]. Interestingly, this increase in inflammatory response
to microbes does not necessarily result in increased clear-
ance of the organism, suggesting that the role of IL-10 in
response to infection is likely pathogen-specific [9]. Very
little has been studied about the role of IL-10 in response
to S. epidermidis infection or biofilm infections specifically,
but elevated levels of IL-10 have been associated with poor
outcomes in patients with S. aureus bacteremia, suggesting
this cytokine may play a role in staphylococcal disease [12].
In these studies, we have adapted our mouse model of
S. aureus CNS catheter infection to generate infection
with S. epidermidis and have used this model to define the
contribution of IL-10 to the inflammatory response to
CNS catheter infection. Our results show that alterations
in IL-10 result in increases in inflammatory mediators and
infiltration of peripheral immune cells but do not signifi-
cantly impact bacterial burdens.
Methods
Mouse strain
All in vivo experiments were performed using 8- to
9-week-old male C57BL/6 or IL-10 knockout (IL-10
KO) mice (The Jackson Laboratory, Bar Harbor, ME).
Each experiment was done independently at three diffe-
rent dates with four to five mice per experimental group
(n = 12–15 mice/group). The protocol for animal use was
approved by the University of Nebraska Medical Center
Institutional Animal Care and Use Committee (protocol
#09-053-08-FC) and is compliant with the National
Institute of Health (NIH) guidelines for the use of
rodents.
Bacterial strain
S. epidermidis 1457 was graciously provided by Dr. Paul
Fey laboratory (University of Nebraska Medical Center).
This isolate was recovered from an infected central
venous catheter and initially characterized by Mack et al.
[13] and has not been laboratory adapted or modified
since its initial characterization.
Catheter preparation and implantation
Hollow bore silicone catheters (2 mm in length, 1 mm
in diameter; Cook Medical Inc., Bloomington, IN) were
incubated with S. epidermidis 1457 overnight to ensure
bacterial adherence to the catheter, resulting in reprodu-
cible catheter colonization of approximately 6 × 107 cfu/
catheter. S. epidermidis required a 4-log higher inoculum
in order to establish infection, in comparison with
our prior work in S. aureus, reflecting the difference
in virulence of these strains [7]. Specifically, the primary
virulence property associated with S. epidermidis is its
ability to form biofilm, as it lacks the production of
virulence factors seen in S. aureus [14]. While higher than
the bacterial inoculum used in our prior S. aureus studies,
this is the lowest bacterial inoculum tested that generated
consistent infection, in order to most closely replicate
natural disease in which small exposures of bacteria at the
time of surgery or subsequent access to the catheter are
believed to cause infection. Subsequently, catheters were
stereotactically implanted in the left lateral ventricle of
anesthetized mice as previously described [7, 8]. In brief,
mice were anesthetized with intraperitoneal (i.p.) injection
of ketamine and xylazine (100 to 200 mg/kg and 5 to
13 mg/kg, respectively) and a 1-cm longitudinal incision
was made in the scalp to expose the skull sutures. The
catheter was placed vertically into the left ventricle as
previously described via a burr hole in the skull placed
using a rodent stereotactic apparatus (Stoelting Co., Wood
Dale, IL). To secure the catheter in place and reduce
bacterial efflux and bleeding, bone wax was used to seal
the burr hole and Vetbond surgical glue to close the
incision (3M, St. Paul, MN). Animals tolerated the proce-
dure well with <1 % mortality. Animals were weighed daily
following surgery to assess weight change as a symptom
of illness.
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Bacterial enumeration from catheters and associated
brain parenchyma
Catheters and associated brain tissue were collected at
the designated time points post-surgery in four to five
mice per group at each time point. Briefly, catheters
were rinsed in sterile phosphate-buffered saline (PBS)
after removal to eliminate non-adherent bacteria and the
biofilms sonicated for 5 min in 500 μl PBS. Tissue within
1 mm of initial catheter placement was homogenized in
500 μl sterile PBS supplemented with a complete prote-
ase inhibitor cocktail tablet (Roche, Basel, Switzerland)
and RNase inhibitor (Promega, Madison, WI) using a
Polytron homogenizer (Brinkmann Instruments, Westbury,
NY). This tissue is referred to as “immediately adjacent
tissue” hereafter. A 100-μl aliquot of these homogenates
and supernatants from sonicated catheters were used to
quantitate bacterial titers via tenfold serial dilutions in
tryptic soy agar plates. These homogenates were also used
to determine cytokine/chemokine levels after centrifugation
and storage at −80 °C as previously described [7, 8].
Cytokine/chemokine analysis
Protein concentrations from brain samples were measured
using a bicinchoninic assay (BCA; Thermo Fisher
Scientific Inc., Rockford, IL) and used to normalize cyto-
kine levels to correct for any variation in tissue sample
size. Inflammatory mediators were measured with mouse
microbead array system according to the manufacturer’s
instruction (MILLIPLEX; EMD Millipore Corp., Billerica,
MA). This assay allowed for simultaneous measurement
of 12 different inflammatory molecules in a single 50-μl
supernatant sample including (IL-1β, IL-4, IL-6, IL-9,
IL-10, IL-12p70, IL-13, CXCL1, CXCL2, CXCL9,
CXCL10, and CCL2). Results were analyzed using Multi-
plex Assay Analysis Software and normalized to tissue
protein level as measured by BCA.
Statistical analysis
Analysis of significant differences between experimental
groups was determined using unpaired Student’s t test
with SigmaStat (SPSS Science, Chicago, IL) at the 95 %
confidence interval. A p value of less than 0.05 was
considered statistically significant.
Results
Catheter-associated bacterial growth predominates
during the initial post-implantation period, consistent
with biofilm formation
To assess the bacteriologic and inflammatory kinetics
of S. epidermidis catheter-associated infection in the
CNS, mice were implanted with silicone catheters pre-
coated with S. epidermidis 1457. At designated time
points following implantation, the catheters were re-
moved and adherent biofilm burdens enumerated for
comparison with the bacteria isolated from the imme-
diately adjacent tissue. As observed in Fig. 1, higher
bacterial burdens were measured after sonication of
infected catheters at days 3 and 5 post-surgery, con-
trasted with the lower bacterial growth observed in the
immediately adjacent tissue. This is consistent with
biofilm infection and with prior experiments utilizing
Fig. 1 S. epidermidis generates a catheter-associated infection in the CNS. This pattern of growth is consistent with biofilm infection. The cultures
from the catheters and parenchyma of the mice implanted with sterile catheters were negative and are not presented in this graph. *p < 0.05
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S. aureus, in which the higher colony counts in associ-
ation with the catheter were confirmed to be visibly con-
sistent with biofilm formation on electron microscopy [7].
This model was capable of reproducing S. epidermidis
catheter-related infection demonstrating its appropriate-
ness to adequately evaluate host immune response to S.
epidermidis infection in the CNS.
S. epidermidis central nervous system catheter infection
induces skewed production of pro- and anti-inflammatory
mediators in the brain
To assess the inflammatory response to S. epidermidis
catheter infection in the CNS, homogenates of imme-
diately adjacent catheter-associated tissue were analyzed
for IL-1β, IL-6, CXCL2, and CXCL1 production by mul-
tianalyte microbead array (Fig. 2). IL-1β was slightly, but
significantly, elevated at day 3, and IL-6 was significantly
increased at multiple time points than the infected
group compared to the uninfected mice. CXCL1 and
CXCL2, the chemokines responsible for early phase
cellular recruitment, were also increased in the tissues
surrounding the infected catheters, suggesting that
innate immune cells may be recruited as part of the
inflammatory response to S. epidermidis infection in the
brain. The pro-inflammatory environment observed in
this model is congruent with results obtained with simi-
lar studies using S. aureus ACH1719 strain [7, 8]. No
differences were noted in levels of Il-4, IL-9, IL-13,
CXCL9, or CCL2 (data not shown).
In contrast to in vitro and in vivo studies utilizing S.
aureus, the pro-inflammatory cytokine IL-12p70 was not
elevated following the infection with S. epidermidis in
this model [15–18]. There was no significant difference
between levels of IL-12p70 in the immediately adjacent
tissues surrounding the infected versus uninfected
catheters (Fig. 3a). The anti-inflammatory cytokine IL-10
was slightly elevated in response to S. epidermidis
infected catheters, demonstrating a potential role for
Fig. 2 An increase in certain pro-inflammatory chemokines and cytokines is observed, similar to previous studies with S. aureus. Catheter-associated
infection in the CNS with S. epidermidis results in an increase in pro-inflammatory cytokines (IL-1β (a); IL-6 (b) and chemokines (CXCL1 (c); CXCL2 (d).
Results were normalized to the amount of total protein recovered to account for differences in tissue sampling size. *p < 0.05
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anti-inflammatory as well as pro-inflammatory path-
ways in response to CNS catheter infection (Fig. 3b).
IL-10 is not required to support S. epidermidis infectivity
but does play a significant role in regulating the immune
response to infection
Given the slight increase in IL-10 noted on multianalyte
microbead array (Fig. 3b), we hypothesized that the
anti-inflammatory properties of IL-10 may create a
permissive environment that facilitates S. epidermidis
infection in the brain. To test this hypothesis, we im-
planted S. epidermidis-infected catheters into the CNS
of wild-type C57BL/6 and IL-10 KO mice and com-
pared their clinical response to infection, bacterial
burdens, and inflammatory responses via multianalyte
microbead array. Surprisingly, bacterial enumeration
at day 3 and day 7 from the catheter and immediately
adjacent tissue showed similar colony counts in IL-10
KO mice compared to wild-type, proving that S.
epidermidis infectivity does not depend on the individ-
ual action of anti-inflammatory cytokine IL-10 (Fig. 4).
Despite the similar bacterial burdens, however, the
IL-10 KO mice showed greater evidence of clinical
illness as measured by percent weight loss (Fig. 5).
This difference becomes apparent by day 3 following
infection, which coincides with high bacterial burdens
(Fig. 4). Interestingly, this time point also coincides
with pro-inflammatory mediator production at day 3,
which was significantly increased in the IL-10 KO
mice (Fig. 6). The IL-10 KO mice had significantly
higher levels of IL-6 and CXCL1 in the immediately
adjacent tissue surrounding the infected catheters,
with a trend toward higher levels of IL-1β and
CXCL2 as well.
Discussion
S. epidermidis and S. aureus are the most common
biofilm-forming bacteria responsible for CSF shunt
infections [19]. These infections hinder the effectiveness
of shunt therapy and inflict an unnecessary burden in
the treatment of pediatric patients, who are known to be
at higher risk for shunt infection, although the mecha-
nisms responsible for this increased risk in children are
not yet defined [19]. Biofilm infections are known to be
difficult to diagnose and recalcitrant to antibiotic treat-
ment, leading to removal of the shunt [19]. This
increases the numbers of surgical procedures needed for
patients, in addition to increasing future infection risks
as revision itself is associated with an increased risk of
shunt infection [19, 20]. Infants are known to have the
most adverse outcomes, such as increased risk of sei-
zures, IQ loss, and up to 10 % death rate in patients with
neurological handicap [21, 22]. Shunt infections also lead
to disproportionate use of hospital days and health-care
dollars [23]. Collectively, these findings highlight the
significance of CNS shunt infection and the need to
better understand the pathophysiology of the disease
with the goal of informing better treatment strategies
that would avoid the need for shunt replacement surgery.
In these studies, we adapted our established model of
S. aureus CNS catheter infection to generate infection
with the more prevalent, but less virulent S. epidermidis
[14, 24]. While S. epidermidis is the cause of most CNS
catheter infections, its primary virulence property is
its ability to form biofilm, as it lacks the production
of virulence factors seen in S. aureus [14]. Catheter-
adherent biofilm loads registered peak values at day 3
post-surgery compared to immediately adjacent tissue
in both models, consistent with biofilm formation and
Fig. 3 There is attenuation of the inflammatory response to S. epidermidis in a catheter infection in the brain, with no increase in IL-12p70 (a) and
an increase in anti-inflammatory cytokine IL-10 (b). This demonstrates a skewed immune response to S. epidermidis distinct from that previously
reported with S. aureus. Results were normalized to the amount of total protein recovered to account for differences in tissue sampling size. *p < 0.05
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planktonic spread of the infection. As we have only evalu-
ated the immediately adjacent tissue in these studies, we
may underestimate bacterial spread throughout the brain.
In the S. aureus model of infection, this pattern of
bacterial growth was visually consistent with biofilm
formation on electron microscopy [7]. Interestingly,
both infection models demonstrate a shift to greater
parenchymal involvement as overall bacterial burdens
lessen in later days of infection [7]. Differences between
the pathogenic natures of these two closely related
species were noted by the earlier decrease in bacterial
burdens and reduced mortality rate in S. epidermidis-
infected mice compared to the prolonged course of in-
fection and greater casualties in the S. aureus model
[7]. Additionally, higher colony counts were necessary
to achieve effective infecting doses with S. epidermidis
(6 × 107 cfu/ml) compared to S. aureus (8.7 × 103 cfu/ml)
[7]. These findings are consistent with the increased mor-
bidity attributable to S. aureus in clinical settings and
reflect the multiplicity of virulence factors known to be
present in S. aureus compared to S. epidermidis [25].
These studies also demonstrate a distinct inflamma-
tory profile with greater evidence of attenuation in
response to S. epidermidis biofilm infection in the CNS
than was seen in our prior studies with S. aureus [7].
As in our prior studies with S. aureus, we observed a
brief increase in inflammatory mediators at early time
points following the implantation of sterile catheters
which likely results from tissue damage; importantly,
this inflammation is consistently less than observed in
response to infected catheters [7, 8]. There is an in-
crease in pro-inflammatory IL-1β, IL-6, CXCL1, and
CXCL2 with S. epidermidis, demonstrating that implant-
mediated S. epidermidis infection elicits a significant
inflammatory response in the brain, similar to prior work
with S. aureus [7]. However, we also observed a small in-
crease in the anti-inflammatory IL-10 and a lack of pro-
inflammatory IL-12p70, suggesting that there are also
anti-inflammatory pathways involved in the response to S.
epidermidis CNS catheter infection. This is similar to
studies of peripheral catheter-associated infections which
have demonstrated anti-inflammatory immune responses
to biofilm infections, suggesting a role for biofilm struc-
ture to modulate host response [26]. Our prior studies in
the brain also suggest an attenuated response to biofilm
infection, with decreased levels of pro-inflammatory medi-
ators observed when comparing biofilm infection to both
parenchymal abscess infections and catheter-associated
Fig. 4 IL-10 is not needed for S. epidermidis to establish catheter-associated infection in the central nervous system. There was no significant
difference between catheter-associated (a) or immediately adjacent tissue (b) bacterial burdens in the wild-type (black bars) versus IL-10 KO
(gray bars) mice at days 3 and 7 following infection. Interestingly, 2 of the 12 IL-10 KO mice had no detectable bacteria in the immediately
adjacent tissue or along the catheter at day 7, while all 12 wild-type mice had measurable bacteria at that time
Fig. 5 IL-10 KO mice displayed higher weight loss than their wild-type
counterparts. Mice were weighed daily, with weight loss percentage
calculated per mouse per day based on starting weight. *p < 0.05
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infection with a biofilm-deficient sarA mutant [8]. Future
studies may utilize biofilm-deficient S. epidermidis
mutants, which would allow us to better dissect if there is
a distinctive effect of biofilm formation in the immune
response to S. epidermidis as well. However, this approach
may not be feasible as biofilm-deficient S. epidermidis
may not be able to establish device-associated infection.
Herein, we report increased IL-10 levels in infected
mice following S. epidermidis CNS catheter infection
compared to the non-infected controls. This suggests a
possible effect of IL-10 in curbing the CNS inflamma-
tory environment to allow non-pathogenic S. epidermi-
dis to cause infection [27, 28]. IL-10 plays a central role
in chronic and acute inflammation, particularly in the
CNS where prolonged contact with pro-inflammatory
cytokines leads to harmful effects on neuronal function,
behavior, and cognition [27, 29–32]. To further study
the role of IL-10 in this model, IL-10 KO mice were
infected to evaluate the bacterial kinetics and immune
response in the absence of this important immune
regulator. Surprisingly, IL-10 deficiency had no impact
in bacterial accumulation in the catheter or immediately
adjacent tissue in the first 7 days post-implantation.
IL-10 may play a role in bacterial clearance in later dates
post-infection, which represents a limitation of the current
studies. As expected IL-1β, IL-6, CXCL1, and CXCL2
levels were increased in IL-10 KO mice. This increase in
pro-inflammatory mediators likely led to the increase in
weight loss in the IL-10 KO mice, as IL-1β and IL-6 have
been shown to play a role in sickness behaviors [33, 34].
TNF-α also plays an important role in sickness behaviors
but was not evaluated in these studies [35, 36]. Height-
ened levels of inflammatory cytokines and chemokines in
IL-10 KO mice demonstrate that IL-10 is important in
controlling immune response in this model. However,
this data also shows the limitations of enhancing pro-
inflammatory responses in an effort to treat CNS
catheter infections, as the increased inflammation
resulted not in improved bacterial clearance but ra-
ther in increased clinical illness.
Fig. 6 IL-10 KO mice had significantly greater production of pro-inflammatory mediators following infection despite similar bacterial burdens to
wild-type mice (a–d). This may explain the greater weight loss observed in these mice and suggests that IL-10 is playing a significant role in
regulating the immune response to CNS catheter infection. Results were normalized to the amount of total protein recovered to account for the
differences in tissue sampling size. *p < 0.05
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While our studies have demonstrated that IL-10 is not
solely responsible for dampening the immune response
to permit infection to occur, it does play a role in modu-
lating the immune response to S. epidermidis infection
in the CNS. This may play a particularly significant role
in infants, who are known to be at higher risk of CNS
catheter infections [2, 4, 19]. In humans, IL-10 appears
to play an important protective role in infants, with
altered IL-10 levels associated with inflammatory condi-
tions such as bronchopulmonary dysplasia, sepsis,
seizures, and colitis [37–40]. Additionally, cord blood
studies suggest that the neonatal immune system is
primed toward increased IL-10 production, with increased
IL-10 release from mononuclear cells following exposure
to neonatal plasma and increased IL-10 expression from
infant monocytes following TLR stimulation [41, 42].
These in vitro studies suggest that IL-10 may play an
important role in regulating the immune response to
infection in young hosts, which is currently being evalu-
ated in vivo in our laboratory. Importantly, while this
disease is more common in children, it is not exclusive to
children and there may be distinct differences between the
adult and infant responses to CNS infection such that
investigation of both adult and infant models is needed.
Defining the contribution of IL-10 to pathology in vivo
is essential as this will allow us to account for both the
multiple antigens and evasion capabilities of clinically
relevant bacteria such as S. epidermidis, as opposed to
single antigens, in addition to the impact of immune re-
sponses on multiple cell types within the brain. The
unique milieu of the CNS includes multiple mechanisms
of cross talk between glia and peripheral immune cells
as a means of protecting the CNS from inflammatory
damage as well as invading pathogens and evaluation in
vivo allows for the best opportunity to model these com-
plex interactions. It is reasonable to suspect that IL-
10 will play a greater role in immune regulation in
infant hosts, given its significant role in neonatal
immunity, and future studies in our laboratory will
expand the current studies to this population.
Conclusions
The difficulty in diagnosing and treating biofilm infections
poses a great challenge in the control of indwelling
device-associated infection in the treatment of hydroceph-
alus. A greater understanding of the immune mechanisms
involved in these events could lead to the development of
better biomarkers of infection and of increased suscep-
tibility to infection. Additionally, immune treatment adju-
vants may be developed that could aid in the treatment of
these infections. Our data suggest that IL-10 may be an
important target for immunomodulation in CNS catheter
infection, as it plays a significant role in shaping the
inflammatory response to S. epidermidis infection in the
brain. Further in vivo studies to decipher the complicated
interplay between the host and the bacterial biofilm is
crucial to improve the outcomes of patients with shunt
infections.
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